Organ dysfunction and failure in liver disease.
暂无分享,去创建一个
D. Adebayo | C. Solé | F. Wong | A. Juanola | N. Tiwari | P. Ginés
[1] P. Kamath,et al. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients with Cirrhosis: Expert Review. , 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] K. Reddy,et al. Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute‐on‐chronic liver failure , 2022, Alimentary pharmacology & therapeutics.
[3] J. Trebicka,et al. Pulmonary impairment independently determines mortality in critically ill patients with acute‐on‐chronic liver failure , 2022, Liver international : official journal of the International Association for the Study of the Liver.
[4] S. Caldwell,et al. Haemostatic alterations and management of haemostasis in patients with cirrhosis. , 2022, Journal of hepatology.
[5] S. Sarin,et al. A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]. , 2022, Journal of hepatology.
[6] N. Mahmud,et al. Discordance in categorization of acute-on-chronic liver failure in the United Network for Organ Sharing database. , 2022, Journal of hepatology.
[7] C. Gregoretti,et al. ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure , 2021, European Respiratory Journal.
[8] K. Reddy,et al. The Prediction of In‐Hospital Mortality in Decompensated Cirrhosis with Acute‐on‐Chronic Liver Failure , 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[9] P. Angeli,et al. Acute-on-Chronic Liver Failure in Cirrhosis , 2021, Journal of clinical medicine.
[10] E. Le Chatelier,et al. Rifaximin reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial. , 2021, Journal of hepatology.
[11] W. Jiménez,et al. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis. , 2021, Journal of hepatology.
[12] C. Trautwein,et al. Granulocyte-Colony Stimulating Factor (G-CSF) to treat acute-on-chronic liver failure, a multicenter randomized trial (GRAFT study). , 2021, Journal of hepatology.
[13] M. Karsdal,et al. Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure , 2021, JHEP reports : innovation in hepatology.
[14] B. Colsch,et al. Untargeted lipidomics uncovers lipid signatures distinguishing severe versus moderate forms of acutely decompensated cirrhosis. , 2021, Journal of hepatology.
[15] F. Saliba,et al. Intensive care management of acute-on-chronic liver failure. , 2021, Journal of hepatology.
[16] Javier Fernández,et al. Management of bacterial and fungal infections in cirrhosis: The MDRO challenge. , 2021, Journal of hepatology.
[17] G. Szabo,et al. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. , 2021, Journal of hepatology.
[18] P. Thuluvath,et al. EASL-CLIF criteria perform better than NACSELD to diagnose and prognosticate ACLF. , 2021, Journal of hepatology.
[19] P. Cortesi,et al. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS). , 2021, Journal of hepatology.
[20] R. Hernaez,et al. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis , 2021, Gut.
[21] R. Moreau,et al. The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis. , 2020, Journal of hepatology.
[22] A. Ferruelo,et al. Liver–lung interactions in acute respiratory distress syndrome , 2020, Intensive Care Medicine Experimental.
[23] M. Manns,et al. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. , 2020, Journal of hepatology.
[24] S. Taylor-Robinson,et al. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. , 2020, Journal of hepatology.
[25] M. Trauner,et al. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. , 2020, Journal of hepatology.
[26] N. Borruel,et al. ALTERATIONS IN GUT MICROBIOME IN CIRRHOSIS AS ASSESSED BY QUANTITATIVE METAGENOMICS. RELATIONSHIP WITH ACUTE-ON-CHRONIC LIVER FAILURE AND PROGNOSIS. , 2020, Gastroenterology.
[27] R. Moreau,et al. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment , 2020, JHEP reports : innovation in hepatology.
[28] P. Angeli,et al. Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome , 2020, Hepatology.
[29] Q. Xie,et al. The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis. , 2020, The American journal of gastroenterology.
[30] D. J. Kim,et al. Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure. , 2020, Journal of hepatology.
[31] A. Singal,et al. Systematic review with meta‐analysis: liver transplant provides survival benefit in patients with acute on chronic liver failure , 2020, Alimentary pharmacology & therapeutics.
[32] D. Gómez-Cabrero,et al. Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis. , 2020, Journal of hepatology.
[33] R. Moreau,et al. Cardiodynamic state is associated with systemic inflammation and fatal acute‐on‐chronic liver failure , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[34] P. Kamath,et al. Model for End‐Stage Liver Disease‐Lactate and Prediction of Inpatient Mortality in Patients With Chronic Liver Disease , 2020, Hepatology.
[35] B. Colsch,et al. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. , 2019, Journal of hepatology.
[36] F. Wong. Clinical Consequences of Infection in Cirrhosis: Organ Failures and Acute‐on‐Chronic Liver Failure , 2019, Clinical liver disease.
[37] R. Jalan,et al. Prognostic Role of Ammonia in Patients With Cirrhosis , 2019, Hepatology.
[38] S. Liangpunsakul,et al. Role of endotoxemia in causing renal dysfunction in cirrhosis , 2019, Journal of Investigative Medicine.
[39] M. Mcphail,et al. Lactate and number of organ failures predict intensive care unit mortality in patients with acute‐on‐chronic liver failure , 2019, Liver international : official journal of the International Association for the Study of the Liver.
[40] N. Mahmud,et al. Patients With Acute on Chronic Liver Failure Grade 3 Have Greater 14‐Day Waitlist Mortality Than Status‐1a Patients , 2019, Hepatology.
[41] Y. Chawla,et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update , 2019, Hepatology International.
[42] Gavin D Perkins,et al. Guidelines on the management of acute respiratory distress syndrome , 2019, BMJ Open Respiratory Research.
[43] K. Reddy,et al. Infections in Cirrhosis , 2019, Current Treatment Options in Gastroenterology.
[44] M. Volk,et al. Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation. , 2019, Gastroenterology.
[45] S. Sarin,et al. Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure , 2019, Hepatology.
[46] J. Farrés,et al. Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival , 2019, Liver international : official journal of the International Association for the Study of the Liver.
[47] F. Nevens,et al. Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[48] I. Barjaktarevic,et al. Acute Respiratory Failure and Pulmonary Complications in End-Stage Liver Disease , 2018, Seminars in Respiratory and Critical Care Medicine.
[49] P. Kamath,et al. Hepatorenal syndrome , 2018, Nature Reviews Disease Primers.
[50] A. Sutton,et al. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis , 2018, Cochrane Database of Systematic Reviews.
[51] J. Trebicka,et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. , 2018, Journal of hepatology.
[52] Q. Ning,et al. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis , 2018, World journal of gastroenterology.
[53] K. Reddy,et al. NACSELD acute‐on‐chronic liver failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosis , 2018, Hepatology.
[54] S. Taylor-Robinson,et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial , 2017, Hepatology.
[55] S. Jaber,et al. Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3. , 2017, Journal of hepatology.
[56] Jun Yu Li,et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure , 2017, Gut.
[57] S. Keenan,et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure , 2017, European Respiratory Journal.
[58] J. Daurès,et al. Impact of acute‐on‐chronic liver failure on 90‐day mortality following a first liver transplantation , 2017, Liver international : official journal of the International Association for the Study of the Liver.
[59] P. Angeli,et al. New diagnostic criteria and management of acute kidney injury. , 2017, Journal of hepatology.
[60] J. Fallowfield,et al. Systematic review with meta‐analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1 , 2017, Alimentary pharmacology & therapeutics.
[61] R. Moreau,et al. Acute-on-chronic liver failure: an update , 2017, Gut.
[62] Richard Moreau,et al. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure , 2016, Hepatology.
[63] F. Nevens,et al. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. , 2016, Journal of hepatology.
[64] D. Ganger,et al. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1. , 2016, Gastroenterology.
[65] S. Moestrup,et al. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF). , 2016, Journal of hepatology.
[66] R. Hirose,et al. Simultaneous Liver–Kidney Allocation Policy: A Proposal to Optimize Appropriate Utilization of Scarce Resources , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[67] Cindy X. Cai,et al. Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albumin. , 2015, Journal of critical care.
[68] S. Sarin,et al. AKI in patients with acute on chronic liver failure is different from acute decompensation of cirrhosis , 2015, Hepatology International.
[69] Min Zheng,et al. Acute‐on‐chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults , 2015, Hepatology.
[70] A. de Gottardi,et al. Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis , 2015, Hepatology.
[71] F. Wong,et al. Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[72] R. Jalan,et al. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. , 2015, Journal of hepatology.
[73] W. Kim,et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites , 2015, Gut.
[74] R. Moreau,et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. , 2014, Journal of hepatology.
[75] A. Gerbes,et al. Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis , 2014, Gut.
[76] K. Reddy,et al. Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures , 2014, Hepatology.
[77] D. Samuel,et al. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. , 2014, Journal of hepatology.
[78] M. Pavesi,et al. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). , 2014, Journal of hepatology.
[79] F. Bendtsen,et al. Lactate metabolism in chronic liver disease , 2013, Scandinavian journal of clinical and laboratory investigation.
[80] R. Moreau,et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.
[81] Antonio Gasbarrini,et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: The RELIEF trial , 2013, Hepatology.
[82] V. Paradis,et al. Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis , 2013, Liver international : official journal of the International Association for the Study of the Liver.
[83] J. Chen,et al. Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure. , 2013, World journal of gastroenterology.
[84] P. Angeli,et al. Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice. , 2012, Journal of hepatology.
[85] R. Jalan,et al. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. , 2012, Journal of hepatology.
[86] Ulrich Treichel,et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. , 2012, Gastroenterology.
[87] Samuel S. Lee,et al. Mechanisms of TNFα-induced cardiac dysfunction in cholestatic bile duct-ligated mice: Interaction between TNFα and endocannabinoids , 2010 .
[88] M. Peterson,et al. Bedside Sublingual Video Imaging of Microcirculation in Assessing Bacterial Infection in Cirrhosis , 2009, Digestive Diseases and Sciences.
[89] A. Sanyal,et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. , 2008, Gastroenterology.
[90] V. Arroyo,et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. , 2008, Gastroenterology.
[91] Vicente Arroyo,et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis , 2007, Postgraduate Medical Journal.
[92] V. Arroyo,et al. Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival , 2006, Hepatology.
[93] J. Russell,et al. Pathophysiology of Septic Shock. , 2018, Critical care clinics.
[94] P. Angeli,et al. Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis. , 2017, Journal of hepatology.